EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment

Xuechun Fang, Junjie Feng, Xingcheng Zhu, Dan Feng, Lei Zheng

Molecular Therapy · 2024-04 · 32 (4) · 890-909

DOI: 10.1016/j.ymthe.2024.02.021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2024-04. Verfasst von Xuechun Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangdong Engineering and Technology Resea…. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Inflammatory Bowel Diseases, Nanoparticles, Colitis. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term use of conventional drugs to treat inflammatory bowel diseases (IBD) and colitis-associated cancer (CAC) has an adverse impact on the human immune system and easily leads to drug resistance, highlighting the urgent need to develop novel biotherapeutic tools with improved activity and limited side effects. Numerous products derived from plant sources have been shown to exert antibacterial, anti-inflammatory and antioxidative stress effects. Plant-derived vesicle-like nanoparticles (PDVLNs) are natural nanocarriers containing lipids, protein, DNA and microRNA (miRNA) with the ability to enter mammalian cells and regulate cellular activity. PDVLNs have significant potential in immunomodulation of macrophages, along with regulation of intestinal microorganisms and friendly antioxidant activity, as well as overcoming drug resistance. PDVLNs have utility as effective drug carriers and potential modification, with improved drug stability. Since immune function, intestinal microorganisms, and antioxidative stress are commonly targeted key phenomena in the treatment of IBD and CAC, PDVLNs offer a novel therapeutic tool. This review provides a summary of the latest advances in research on the sources and extraction methods, applications and mechanisms in IBD and CAC therapy, overcoming drug resistance, safety, stability, and clinical application of PDVLNs. Furthermore, the challenges and prospects of PDVLN-based treatment of IBD and CAC are systematically discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis-Associated NeoplasmsInflammatory Bowel DiseasesNanoparticlesColitisAnimalsHumansAnti-Inflammatory AgentsMacrophagesMammals

Stichwörter der Autor:innen

antioxidantcolitis-associated cancerimmunomodulation of macrophagesinflammatory bowel diseaseovercoming drug resistanceplant-derived vesicle-like nanoparticlesregulation of intestinal microorganisms

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Nanfang Hospital, Southern…
  • Medical Laboratory Department, Second People's Hospital, Qujing 655000, China.
  • Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou 510182, China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China
  • National Science Fund for Distinguished Young Scholars

Zitieren

APA

Fang, X., Feng, J., Zhu, X., Feng, D., & Zheng, L. (2024). Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment. Molecular Therapy, 32(4), 890-909. https://doi.org/10.1016/j.ymthe.2024.02.021

Vancouver

Fang X, Feng J, Zhu X, Feng D, Zheng L. Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment. Molecular Therapy. 2024;32(4):890-909. doi:10.1016/j.ymthe.2024.02.021

BibTeX
@article{Fang2024,
  author = {Fang, Xuechun and Feng, Junjie and Zhu, Xingcheng and Feng, Dan and Zheng, Lei},
  title = {Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment},
  journal = {Molecular Therapy},
  year = {2024},
  volume = {32},
  number = {4},
  pages = {890--909},
  doi = {10.1016/j.ymthe.2024.02.021}
}
Kostenlos starten →